Pistachio Intake, Satiety and Body Weight Control in Healthy Adult Women (APIS)

May 3, 2018 updated by: Rene' Yamashiro

Acute Satiety and Energy Compensation After Consumption of a Pistachio Snack and Longer Term Consequences on Satiety, Anthropometry, and Body Composition After a Nutritional Intervention With Daily Consumption of the Pistachio Snack

The main goal of the study is to confirm that, due to their rich nutritional content in protein, polyunsaturated fatty acids, vitamins and minerals of interest (calcium and magnesium), the regular consumption of the recommended amount of pistachios by adult women will elicit appropriate satiety and compensation in the daily energy intake, and improve diet quality, anthropometry and body composition.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

The expected endpoint is to demonstrate that the daily consumption of a snack of pistachios by healthy women, as recommended in the next National Program for Nutrition and Health (program PNNS, France), elicits adequate satiety and does not induce weight gain but rather improves diet quality, body composition and body fat mass distribution (less abdominal fat).

The study will be a 16 weeks randomized controlled open trial, single-center, including two parallel groups of 30 female participants (block randomization stratified on habitual energy intake and initial body weight according to the consort-statement checklist).

The main working hypothesis is a demonstration of the "non inferiority" of the effects of the pistachio intervention on body weight versus no snack consumption. The investigators hypothesize that there will be no significant difference in body weight change due to pistachios consumption. The two-sided 95% confidence interval on the intra-patient difference (before minus after the pistachio intervention) will be provided through the appropriate contrasts.

Study Type

Interventional

Enrollment (Anticipated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Rhône
      • Givors, Rhône, France, F-69700
        • Recruiting
        • CreaBio Rhône-Alpes
        • Contact:
        • Principal Investigator:
          • Marc Fantino, MD, PhD, Pr

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 50 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  1. Healthy women;
  2. Age: lower age limit 18 years, upper age limit: 50 years (included);
  3. Body Mass Index: lower limit 19 kg/m²; upper limit 29.9 kg/m²; weight stable within ± 2 kg in the last 3 months;
  4. Habitual energy intake, as indicated by an initial intake report (diary method, three days) within the 95% confidence interval (CI) of the habitual energy intake of a similar population (as provided by internal reference data collected by CREABio-RA from previous studies in similar conditions);
  5. Participant not pregnant, not presently breast feeding or having breastfed in the last 3 months, and not planning to become pregnant during the study (negative pregnancy test at inclusion or morning of V1);
  6. Pre-menopausal participant on effective contraception since at least 3 months (regular 28-day cycle) and who agree to continue their contraception throughout the study;
  7. Participant registered with the French Social Security;
  8. participant having signed informed consent

Exclusion Criteria:

  1. Subject under legal protection or deprived of liberty by judicial or administrative decision.
  2. Currently diagnosed somatic pathology;
  3. On medication affecting metabolism, weight, energy intake, or energy expenditure in the last 6 months;
  4. Major psychiatric disorder, particularly eating disorders as defined by the DSM-V;
  5. High level of "Restrained Eating" or "Disinhibition", as revealed by the TFEQ or similar questionnaire;
  6. Strong initial dislike of nuts, specially pistachios, as revealed by questioning about food habits initial dietary questionnaire;
  7. Habitual consumption of pistachios as revealed by the 3-d intake report (more than twice a week);
  8. Participants smoking more than 10 cigarettes per day or planning to stop smoking in the next 3 months;
  9. Currently pregnant, lactating (as specified in article L1121-5 of the Public Health Code) or less than 6 month post-partum;
  10. Any kind of food allergy, especially allergies or intolerance to nuts;
  11. Participant not capable of understanding the constraints of the study, who does not agree to abide, and/or unable to communicate normally with investigators;
  12. Person currently participating in another clinical study, or having used up her annual entitlement to compensation for participation in biomedical studies (4500 €).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Pistachio diet
Incorporates 44 g (1 serving) of pistachios into a daily diet
Dailly 44 g unsalted pistachios snack for 12 weeks
No Intervention: Control
No pistachio consumption

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Body weight
Time Frame: 12 weeks
Body weight in kg
12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total daily energy intake
Time Frame: 12 weeks
Total daily energy intake in kcal
12 weeks
Appetite ratings
Time Frame: 12 weeks
Appetite ratings measured on visual analogic scalls of 100 mm
12 weeks
Body weight index
Time Frame: 12 weeks
Body weight index in kg/m2
12 weeks
Body fat mass
Time Frame: 12 weeks
Body fat mass in kg
12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Marc FANTINO, MD, PhD, Pr., CreaBio Rhône-Alpes

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 27, 2018

Primary Completion (Anticipated)

August 1, 2019

Study Completion (Anticipated)

August 1, 2019

Study Registration Dates

First Submitted

April 22, 2018

First Submitted That Met QC Criteria

May 3, 2018

First Posted (Actual)

May 16, 2018

Study Record Updates

Last Update Posted (Actual)

May 16, 2018

Last Update Submitted That Met QC Criteria

May 3, 2018

Last Verified

May 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • APIS
  • ID RCB : 20107-A031 (Registry Identifier: Agence Nationale de Sécurité du Médicament (ANSM, France))
  • APG01-0117 (Other Identifier: CreaBio-RA)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on Pistachio

3
Subscribe